======= IL31RA ======= == Gene Information == * **Official Symbol**: IL31RA * **Official Name**: interleukin 31 receptor A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=133396|133396]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NI17|Q8NI17]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IL31RA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IL31RA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609510|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the type I cytokine receptor family. This receptor, with homology to gp130, is expressed on monocytes, and is involved in IL-31 signaling via activation of STAT-3 and STAT-5. It functions either as a monomer, or as part of a receptor complex with oncostatin M receptor (OSMR). Several alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jun 2011]. * **UniProt Summary**: N/A |fn3| |IL6Ra-bind| |EpoR lig-bind| |negative regulation of macrophage activation| |monocyte differentiation| |mononuclear cell differentiation| |macrophage differentiation| |receptor signaling pathway via JAK-STAT| |receptor signaling pathway via STAT| |cytokine binding| |cytokine receptor activity| |regulation of macrophage activation| |positive regulation of tyrosine phosphorylation of STAT protein| |presynaptic membrane| |regulation of tyrosine phosphorylation of STAT protein| |positive regulation of receptor signaling pathway via JAK-STAT| |positive regulation of receptor signaling pathway via STAT| |myeloid leukocyte differentiation| |regulation of receptor signaling pathway via JAK-STAT| |regulation of receptor signaling pathway via STAT| |negative regulation of leukocyte activation| |positive regulation of peptidyl-tyrosine phosphorylation| |negative regulation of cell activation| |receptor complex| |myeloid cell differentiation| |regulation of peptidyl-tyrosine phosphorylation| |transcription coactivator activity| |axon| |leukocyte differentiation| |MAPK cascade| |signal transduction by protein phosphorylation| |external side of plasma membrane| |negative regulation of immune system process| |protein kinase binding| |transmembrane receptor protein tyrosine kinase signaling pathway| |cell junction| |hemopoiesis| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |regulation of cell activation| |immune system development| |cytokine-mediated signaling pathway| |enzyme linked receptor protein signaling pathway| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |positive regulation of cell population proliferation| |protein phosphorylation| |negative regulation of cell death| |cellular response to cytokine stimulus| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |response to cytokine| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of protein modification process| |phosphorylation| |defense response| |regulation of protein phosphorylation| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |positive regulation of signal transduction| |regulation of immune system process| |regulation of cell death| |intracellular signal transduction| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|1.76| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|1.93| |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|2.06| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12005 * **Expression level (log2 read counts)**: -0.68 {{:chemogenomics:nalm6 dist.png?nolink |}}